Stockwatch

If you had invested ₹10,000 in Glenmark Pharmaceuticals in 2025

Worth at the close on 30 Oct 2026
₹12,209
+22.1% Gain of ₹2,209 over 12 months.
Invested
₹10,000
On
30 Oct 2025
Price then
₹1,883
Price now
₹2,299
Annualised
+22.1%
Multiple
1.22×
₹8,000₹9,000₹10,000₹11,000₹12,000₹13,000₹14,00020252026
Glenmark Pharmaceuticals NIFTY 50, same money same dates What you put in

Value of ₹10,000 invested on 30 Oct 2025, month by month.

Was that any good?

The same money, somewhere else

WhereWorth nowChange Against GLENMARK
Glenmark Pharmaceuticals ₹12,209 +22.1% —
NIFTY 50 ₹8,908 -10.9% ₹3,301 more
Fixed deposit at 6.5% ₹10,650 +6.5% ₹1,559 more

The NIFTY 50 figure is the index itself over the same dates, which like this page counts price only and no dividends — so the two are measured the same way. The fixed deposit line assumes a steady 6.5% a year for the whole period. No bank held one rate that long: Indian deposit rates ran from around 9% in 2014 to about 5.5% in 2021. Treat it as a yardstick, not a record of what a deposit actually paid.

Year by year

YearChange
2026 +12.9%
2025 +26.5%
2024 +88.4%
2023 +101.3%
2022 -19.8%
2021 +7.1%

Glenmark Pharmaceuticals on the record

All-time high
₹2,515
28 Aug 2026
52-week range
₹1,793 – ₹2,538
Deepest fall
-80.5%
01 Nov 2016 to 23 Mar 2020
Market cap
₹64,875 Cr

How this was worked out

₹10,000 at ₹1,883 a share buys 5.31 shares. Held to the close of 30 Oct 2026 at ₹2,299, those shares are worth ₹12,209. Dividends are not included, and neither are brokerage, taxes or charges — the real figure would differ on both counts.

Data covers 19 May 2016 to 30 Oct 2026 (2,588 trading days), from end-of-day NSE prices. This page is a record of what prices did. It is not advice, and nothing here is a recommendation to buy or sell — read the disclaimer.

Companies of a similar size